Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1983]
News [3215]
Articles [134]
Editorials [3]
Conferences [121]
elearning [18]
AACR 2012: New, potent epigenetic drug for myelodysplastic syndromes, leukaemia
AACR 2012: New, potent epigenetic drug for myelodysplastic syndromes, leukaemia
AACR 2012: Scientists reprogram cancer cells with low doses of epigenetic drugs
AACR 2012: Scientists reprogram cancer cells with low doses of epigenetic drugs
AACR 2012: Immunotherapy and chemotherapy regimen may prolong survival in advanced cancers
AACR 2012: Immunotherapy and chemotherapy regimen may prolong survival in advanced cancers
AACR 2012: Study of whole genome sequencing evaluates potential for predicting cancer risk
AACR 2012: Study of whole genome sequencing evaluates potential for predicting cancer risk
AACR 2012: Metformin may protect against liver cancer
AACR 2012: Metformin may protect against liver cancer
AACR: 2012: Investigational targeted drug induces responses in aggressive lymphomas
AACR: 2012: Investigational targeted drug induces responses in aggressive lymphomas
Scientists find new drug target for hard-to-treat leukaemia
Scientists find new drug target for hard-to-treat leukaemia
Experts call for 'urgent reform' of side-effect reporting on cancer trials
Experts call for 'urgent reform' of side-effect reporting on cancer trials
Few young women with cancer take steps to preserve fertility during treatments
Few young women with cancer take steps to preserve fertility during treatments
Scientists reprogram cancer cells with low doses of epigenetic drugs
Scientists reprogram cancer cells with low doses of epigenetic drugs

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation